blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0717736

EP0717736 - PHOSPHORUS DERIVATIVES TO TREAT AIDS [Right-click to bookmark this link]
Former [1996/26]POLAR-SUBSTITUTED HYDROCARBONS
[2003/48]
StatusNo opposition filed within time limit
Status updated on  25.03.2005
Database last updated on 31.08.2024
Most recent event   Tooltip28.12.2007Lapse of the patent in a contracting state
New state(s): PT		published on 30.01.2008  [2008/05]
Applicant(s)For all designated states
Narhex Limited
11th floor, 3A Chater Road
Hong Kong / HK
[N/P]
Former [1996/26]For all designated states
NARHEX LIMITED
11th floor, 3A Chater Road
Hong Kong / HK
Inventor(s)01 / GROBELNY, Damian
11 Longfield Court
Watsonia North, VIC 3087 / AU
[1996/26]
Representative(s)Ablewhite, Alan James, et al
Marks & Clerk 90 Long Acre
London WC2E 9RA / GB
[N/P]
Former [2001/18]Ablewhite, Alan James, et al
MARKS & CLERK, 57/60 Lincoln's Inn Fields
London WC2A 3LS / GB
Former [1996/26]Lord, Hilton David, et al
MARKS & CLERK, 57-60 Lincoln's Inn Fields
London WC2A 3LS / GB
Application number, filing date94926731.412.09.1994
[1996/26]
WO1994AU00538
Priority number, dateAU1993PM0116110.09.1993         Original published format: AU PM116193
AU1994PM0644624.06.1994         Original published format: AU PM644694
[1996/26]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9507269
Date:16.03.1995
Language:EN
[1995/12]
Type: A1 Application with search report 
No.:EP0717736
Date:26.06.1996
Language:EN
The application published by WIPO in one of the EPO official languages on 16.03.1995 takes the place of the publication of the European patent application.
[1996/26]
Type: B1 Patent specification 
No.:EP0717736
Date:19.05.2004
Language:EN
[2004/21]
Search report(s)International search report - published on:AU16.03.1995
(Supplementary) European search report - dispatched on:EP15.07.1996
ClassificationIPC:C07D255/02, C07D487/04, C07F9/60, C07F9/6509, C07D213/40
[1996/34]
CPC:
C07D237/04 (EP); C07D255/02 (EP,KR); C07C243/18 (EP);
C07C243/28 (EP); C07C243/32 (EP); C07C243/34 (EP);
C07C251/80 (EP); C07C255/13 (EP); C07C255/24 (EP);
C07C271/20 (EP); C07C271/22 (EP); C07C281/02 (EP);
C07D207/14 (EP); C07D207/416 (EP); C07D209/48 (EP);
C07D211/28 (EP); C07D211/58 (EP); C07D211/72 (EP);
C07D213/30 (EP); C07D213/40 (EP); C07D213/56 (EP);
C07D213/75 (EP); C07D213/80 (EP); C07D215/14 (EP);
C07D231/04 (EP); C07D231/12 (EP); C07D231/54 (EP);
C07D233/56 (EP); C07D237/30 (EP); C07D237/32 (EP);
C07D239/04 (EP); C07D243/10 (EP); C07D245/02 (EP);
C07D249/08 (EP); C07D257/04 (EP); C07D265/06 (EP);
C07D265/30 (EP); C07D295/13 (EP); C07D295/26 (EP);
C07D303/36 (EP); C07D307/12 (EP); C07D401/06 (EP);
C07D401/12 (EP); C07D401/14 (EP); C07D403/12 (EP);
C07D405/06 (EP); C07D405/12 (EP); C07D405/14 (EP);
C07D471/04 (EP); C07D471/08 (EP); C07D487/04 (EP,KR);
C07D487/08 (EP); C07D491/04 (EP); C07D495/04 (EP);
C07F9/091 (EP); C07F9/093 (EP); C07F9/1411 (EP);
C07F9/1412 (EP); C07F9/5532 (EP); C07F9/572 (EP);
C07F9/58 (EP); C07F9/60 (EP); C07F9/62 (EP);
C07F9/6506 (EP); C07F9/650994 (EP); C07F9/65583 (EP);
C07F9/65586 (EP); C07F9/6561 (EP); C07F9/65742 (EP);
C07F9/65744 (EP); C07K5/06139 (EP); C07K5/06191 (EP);
A61K38/00 (EP); C07C2601/14 (EP); C07C2601/16 (EP);
C07C2602/10 (EP); C07C2603/24 (EP) (-)
Former IPC [1996/26]C07D255/02, C07D487/04, C07F9/60, C07F9/6509
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1996/26]
TitleGerman:PHOSPHORDERIVATE ZUR BEHANDLUNG VON AIDS[2003/48]
English:PHOSPHORUS DERIVATIVES TO TREAT AIDS[2003/48]
French:DERIVES PHOSPHORES POUR TRAITER LE SIDA[2003/48]
Former [1996/26]POLAR-SUBSTITUIERTE KOHLENWASSERSTOFFE
Former [1996/26]POLAR-SUBSTITUTED HYDROCARBONS
Former [1996/26]HYDROCARBURES A SUBSTITUANTS POLAIRES
Entry into regional phase07.03.1996National basic fee paid 
07.03.1996Search fee paid 
07.03.1996Designation fee(s) paid 
07.03.1996Examination fee paid 
Examination procedure10.04.1995Request for preliminary examination filed
International Preliminary Examining Authority: AU
07.03.1996Examination requested  [1996/26]
14.12.1998Despatch of a communication from the examining division (Time limit: M06)
18.06.1999Reply to a communication from the examining division
11.05.2000Despatch of a communication from the examining division (Time limit: M06)
21.02.2001Reply to a communication from the examining division
24.04.2002Despatch of a communication from the examining division (Time limit: M06)
09.12.2002Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
18.02.2003Reply to a communication from the examining division
20.03.2003Despatch of a communication from the examining division (Time limit: M06)
24.09.2003Reply to a communication from the examining division
10.11.2003Communication of intention to grant the patent
11.03.2004Fee for grant paid
11.03.2004Fee for publishing/printing paid
Opposition(s)22.02.2005No opposition filed within time limit [2005/19]
Request for further processing for:18.02.2003Request for further processing filed
18.02.2003Full payment received (date of receipt of payment)
Request granted
04.03.2003Decision despatched
20.02.2001Request for further processing filed
20.02.2001Full payment received (date of receipt of payment)
Request granted
29.03.2001Decision despatched
Fees paidRenewal fee
12.09.1996Renewal fee patent year 03
10.09.1997Renewal fee patent year 04
09.09.1998Renewal fee patent year 05
09.03.2000Renewal fee patent year 06
08.03.2001Renewal fee patent year 07
11.03.2002Renewal fee patent year 08
12.09.2002Renewal fee patent year 09
12.03.2004Renewal fee patent year 10
Penalty fee
Additional fee for renewal fee
30.09.199906   M06   Fee paid on   09.03.2000
30.09.200007   M06   Fee paid on   08.03.2001
30.09.200108   M06   Fee paid on   11.03.2002
30.09.200310   M06   Fee paid on   12.03.2004
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT19.05.2004
ES19.05.2004
DK19.08.2004
GR19.08.2004
SE19.08.2004
LU12.09.2004
MC30.09.2004
PT19.10.2004
[2008/05]
Former [2007/16]AT19.05.2004
ES19.05.2004
DK19.08.2004
GR19.08.2004
SE19.08.2004
LU12.09.2004
MC30.09.2004
Former [2005/22]AT19.05.2004
DK19.08.2004
GR19.08.2004
SE19.08.2004
MC30.09.2004
Former [2005/18]AT19.05.2004
DK19.08.2004
GR19.08.2004
SE19.08.2004
Former [2005/11]AT19.05.2004
GR19.08.2004
SE19.08.2004
Former [2005/06]GR19.08.2004
SE19.08.2004
Former [2004/52]SE19.08.2004
Documents cited:Search[X]  - KONG-TECK CHONG ET AL., "Peptidomimetic HIV protease inhibitors: phosphate prodrugs with improved biological activities", JOURNAL OF MEDICINAL CHEMISTRY, WASHINGTON US, (19930820), vol. 36, no. 17, pages 2575 - 2577, XP002007120 [X] 1-7,20-23 * complete document *

DOI:   http://dx.doi.org/10.1021/jm00069a018
International search[X]AU3570089  (UPJOHN CO);
 [X]AU4566589  (HOECHST AG);
 [X]AU4611589  (HOECHST AG);
 [X]AU4230889  (MOLECULAR THERAPEUTICS INC);
 [X]WO9009191  (SCHRAMM WOLFGANG [DE], et al);
 [X]AU5371690  (HOECHST AG);
 [X]AU6322190  (HOECHST AG);
 [X]AU6633490  (UPJOHN CO);
 [X]WO9108221  (WISCONSIN ALUMNI RES FOUND [US], et al);
 [X]EP0432595  (BAYER AG [DE]);
 [X]WO9110442  (SMITHKLINE BEECHAM CORP [US]);
 [X]AU7131991  (BIO MEGA/BOEHRINGER INGELHEIM RES INC);
 [X]AU7132391  (BIO MEGA/BOEHRINGER INGELHEIM RES INC);
 [X]AU7132091  (BIO MEGA/BOEHRINGER INGELHEIM RES INC);
 [X]AU7732691  (CIBA GEIGY AG);
 [X]AU8205491  (DU PONT MERCK PHARMA);
 [X]AU8191091  (SMITHKLINE BEECHAM CORP);
 [X]AU8231391  (SMITHKLINE BEECHAM CORP);
 [X]AU8320691  (SMITHKLINE BEECHAM CORP);
 [X]AU8740991  (UPJOHN CO);
 [X]AU8587791  (MERCK PATENT GMBH);
 [X]AU8759491  (UPJOHN CO);
 [X]US5116835  (RUEGER WOLFGANG [DE], et al);
 [X]AU8730991  (HOECHST AG);
 [X]AU9053191  (MONSANTO CO);
 [X]AU9085191  (MONSANTO CO);
 [X]AU9092591  (MONSANTO CO);
 [X]AU9125191  (MONSANTO CO);
 [X]AU9133291  (MONSANTO CO);
 [X]AU8890091  (JAPAN ENERGY CORP);
 [X]AU9122391  (SMITHKLINE BEECHAM CORP);
 [X]US5126326  (ANDERSON PAUL C [CA], et al);
 [X]AU8994191  (AMERICAN CYANAMID CO);
 [X]US5132400  (GAMMILL RONALD B [US], et al);
 [X]AU1081292  (SANKYO CO);
 [X]AU9179091  (AVENTIS INC);
 [X]US5145951  (VOGES KLAUS-PETER [DE], et al);
 [X]WO9215319  (SMITHKLINE BEECHAM CORP [US]);
 [X]WO9221696  (STANFORD RES INST INT [US]);
 [XP]EP0519433  (HOECHST AG [DE]);
 [X]AU1835592  (HOECHST AG);
 [X]AU1937392  (NOVARTIS AG);
 [X]AU2194492  (SANDOZ LTD);
 [X]AU2412992  ;
 [X]EP0528242  (BAYER AG [DE]);
 [X]AU2469092  (SCHERING CORP);
 [X]AU2288992  (NOVARTIS AG);
 [X]US5198426  (HAMBY JAMES M [US], et al);
 [X]AU2642492  (SMITHKLINE BEECHAM CORP);
 [X]US5212157  (ANDERSON PAUL C [CA], et al);
 [X]US5215968  (NICKEL WOLF-ULRICH [DE], et al);
 [X]AU3162893  (LABORATOIRES MAYOLY SPINDLER S A R L, et al);
 [X]US5221665  (SKILES JERRY W [US]);
 [X]US5221667  (KALTENBRONN JAMES S [US], et al);
 [XP]AU3516593  (BIO MEGA/BOEHRINGER INGELHEIM RES INC);
 [XP]AU3739193  (NARHEX LTD);
 [XP]US5250563  (CHEN SHIEH-SHUNG T [US], et al);
 [XP]AU3880893  (BIO MEGA/BOEHRINGER INGELHEIM RES INC);
 [XP]AU3562193  (CIBA GEIGY AG);
 [XP]AU3716093  (BAYER AG);
 [XP]US5268361  (ALMQUIST RONALD G [US], et al);
 [XP]EP0574135  (NIPPON MINING CO [JP]);
 [XP]AU4123093  (HOFFMANN LA ROCHE);
 [XP]AU4165993  (SQUIBB & SONS INC);
 [XP]US5294720  (JADHAV PRABHAKAR K [US], et al);
 [XP]US5296604  (HANKO RUDOLF H [US], et al);
 [X]AU4493093  (BAYER AG);
 [XP]AU4907293  (NOVARTIS AG);
 [E]AU6207094  (HOECHST AG)
 [X]  - CHIMICA OGGI, May 1991, TOMASSELLI et al., "The complexities of AIDS: An assesment of the HIV protease as a therapeutic target", pages 6 to 27.
 [X]  - JOURNAL OF MEDICINAL CHEMISTRY, Volume 34, Number 8, August 1991, HUFF J R., "HIV Protease: A novel chemotherapeutic target for AIDS", pages 2305 to 2314.
    [ ] - THE MERCK INDEX, 11th Edition, 1989, MERCK & CO. INC., (RAHWAY N J, USA), Monograph Number: 32, 36, 47, 423, 481, 1507, 1540, 1543, 1575, 1591, 1592, 1593, 1597, 2785, 3676, 3679, 3680, 3681, 3716, 3718, 3751, 3755, 5760, 5865, 5867, 5868, 5938, 6001, 6047, 7809, 7811, 7835, 7836, 7837, 7839, 7854, 7855, 9247, 9257, 9629.
    [ ] - DICTIONARY OF ORGANIC COMPOUNDS, J. Buckingham, 5th Edition, Volumes One to Five, 1982, and First to Tenth Supplements, 1983-1992, CHAPMAN & HALL (NEW YORK, USA), DOC Numbers: A-00943, A-01166, A-02605, A-2609, B-03483, C-03037, E-00484, E-00497, E-00671, E-00792, E-00802, E-01150, H-01166, H-01411, H-03303, M-00319,
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.